"Moderna's mRNA Breakthrough in Rare-Disease Trial"

Moderna, known for its Covid-19 vaccine, is making progress in developing therapies using mRNA, with early study results showing promise for a rare-disease therapy targeting propionic acidemia. The treatment demonstrated potential in reducing life-threatening metabolic emergencies in some participants, indicating progress in Moderna's efforts to turn mRNA into medicines.